Lin, Anqi

Crosstalk Between the MSI Status and Tumor Microenvironment in Colorectal Cancer

Lin, A., Zhang, J., & Luo, P. (2020) · Frontiers in Immunology

Cancer Immunotherapy and BiomarkersGenetic factors in colorectal cancer

Cited by 358

Psychiatric disorders associated with immune checkpoint inhibitors: a pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database

Zhou, C., Peng, S., Lin, A., Jiang, A., Peng, Y., Gu, T., Liu, Z., Cheng, Q., Zhang, J., & Luo, P. (2023) · eClinicalMedicine

Cancer Immunotherapy and BiomarkersPharmacovigilance and Adverse Drug Reactions

Cited by 213

CAMOIP: a web server for comprehensive analysis on multi-omics of immunotherapy in pan-cancer

Lin, A., Qi, C., Wei, T., Li, M., Cheng, Q., Liu, Z., Luo, P., & Zhang, J. (2022) · Briefings in Bioinformatics

Cancer Immunotherapy and BiomarkersBioinformatics and Genomic Networks

Cited by 152

Gamma delta T-cell-based immune checkpoint therapy: attractive candidate for antitumor treatment

Gao, Z., Bai, Y., Lin, A., Jiang, A., Zhou, C., Cheng, Q., Liu, Z., Chen, X., Zhang, J., & Luo, P. (2023) · Molecular Cancer

Cancer Immunotherapy and BiomarkersT-cell and B-cell Immunology

Cited by 138

Advancing pharmaceutical research: A comprehensive review of cutting-edge tools and technologies

Chen, J., Lin, A., & Luo, P. (2024) · Current Pharmaceutical Analysis

Computational Drug Discovery MethodsScience, Research, and Medicine

Cited by 112

The role of DNA damage repair (DDR) system in response to immune checkpoint inhibitor (ICI) therapy

Shi, C., Qin, K., Lin, A., Jiang, A., Cheng, Q., Liu, Z., Zhang, J., & Luo, P. (2022) · Journal of Experimental & Clinical Cancer Research

Cancer Immunotherapy and BiomarkersDNA Repair Mechanisms

Cited by 85

HPVTIMER: A shiny web application for tumor immune estimation in human papillomavirus‐associated cancers

Liu, L., Xie, Y., Yang, H., Lin, A., Dong, M., Wang, H., Zhang, C., Liu, Z., Cheng, Q., Zhang, J., et al. (2023) · iMeta

Cancer Immunotherapy and BiomarkersCervical Cancer and HPV Research

Cited by 62

DNAH10 mutation correlates with cisplatin sensitivity and tumor mutation burden in small-cell lung cancer

Li, M., Lin, A., Luo, P., Shen, W., Xiao, D., Gou, L., Zhang, J., & Guo, L. (2020) · Aging

Lung Cancer Research StudiesLung Cancer Treatments and Mutations

Cited by 62

ATM Mutations Benefit Bladder Cancer Patients Treated With Immune Checkpoint Inhibitors by Acting on the Tumor Immune Microenvironment

Yi, R., Lin, A., Cao, M., Xu, A., Luo, P., & Zhang, J. (2020) · Frontiers in Genetics

Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments

Cited by 60

Heterogeneity of Intratumoral Microbiota Within the Tumor Microenvironment and Relationship to Tumor Development

Gao, Z., Jiang, A., Li, Z., Zhu, L., Mou, W., Shen, W., Luo, P., Tang, B., Zhang, J., & Lin, A. (2025) · Med Research

Gut microbiota and healthBacterial Cancer Therapy

Cited by 51

Microbiota boost immunotherapy? A meta-analysis dives into fecal microbiota transplantation and immune checkpoint inhibitors

Lin, A., Huang, L., Jiang, A., Zhu, L., Mou, W., Li, Y., Zhang, C., Liu, Z., Zhang, J., Cheng, Q., et al. (2025) · BMC Medicine

Cancer Immunotherapy and BiomarkersGut microbiota and health

Cited by 46

The metabolic dialogue between intratumoural microbes and cancer: implications for immunotherapy

Situ, Y., Zhang, P., Zhang, C., Jiang, A., Zhang, N., Zhu, L., Mou, W., Liu, Z., Wong, H. Z. H., Zhang, J., et al. (2025) · eBioMedicine

Gut microbiota and healthCancer Immunotherapy and Biomarkers

Cited by 45

The Evaluation of Generative AI Should Include Repetition to Assess Stability

Zhu, L., Mou, W., Hong, C., Yang, T., Lai, Y., Qi, C., Lin, A., Zhang, J., & Luo, P. (2024) · JMIR mHealth and uHealth

Artificial Intelligence in Healthcare and EducationArtificial Intelligence in Healthcare

Cited by 38

MHC-II Signature Correlates With Anti-Tumor Immunity and Predicts anti-PD-L1 Response of Bladder Cancer

Yi, R., Hong, S., Zhang, Y., Lin, A., Ying, H., Zou, W., Wang, Q., Wei, T., Cheng, Q., Zhu, W., et al. (2022) · Frontiers in Cell and Developmental Biology

Cancer Immunotherapy and BiomarkersBladder and Urothelial Cancer Treatments

Cited by 37

Genomic analysis of biomarkers related to the prognosis of acute myeloid leukemia

Li, G., Gao, Y., Li, K., Lin, A., & Jiang, Z. (2020) · Oncology Letters

Acute Myeloid Leukemia ResearchCancer Genomics and Diagnostics

Cited by 35

STAGER checklist: Standardized testing and assessment guidelines for evaluating generative artificial intelligence reliability

Chen, J., Zhu, L., Mou, W., Lin, A., Zeng, D., Qi, C., Liu, Z., Jiang, A., Tang, B., Shi, W., et al. (2024) · iMetaOmics

Artificial Intelligence in Healthcare and EducationArtificial Intelligence in Healthcare

Cited by 33

Microbiome meets immunotherapy: unlocking the hidden predictors of immune checkpoint inhibitors

Huang, L., Li, Y., Zhang, C., Jiang, A., Zhu, L., Mou, W., Li, K., Zhang, J., Cui, C., Cui, X., et al. (2025) · npj Biofilms and Microbiomes

Cancer Immunotherapy and BiomarkersGut microbiota and health

Cited by 28

TNF-Alpha Pathway Alternation Predicts Survival of Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer

Lin, A., Zhang, H., Meng, H., Deng, Z., Gu, T., Luo, P., & Zhang, J. (2021) · Frontiers in Immunology

Cancer Immunotherapy and BiomarkersLung Cancer Treatments and Mutations

Cited by 27

Evaluating the potential risks of employing large language models in peer review

Zhu, L., Lai, Y., Xie, J., Mou, W., Huang, L., Qi, C., Yang, T., Jiang, A., Gan, W., Zeng, D., et al. (2025) · Clinical and Translational Discovery

Academic integrity and plagiarismEthics and Social Impacts of AI

Cited by 15